This award recognizes Dr. Nkrumah-Elie's dedication to advancing scientific excellence for ChromaDex's leading external research program and mentorship in the dietary supplement industry LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide...
Flow Beverage (FLOW / FLWBF) Company Webcast
Flow Beverage Corp. (TSX: FLOW / OTCQX: FLWBF) is one of the fastest-growing premium water companies in North America. Founded in 2014, Flow’s mission since day one has been to reduce environmental impacts by providing sustainably sourced natural mineral spring water...
ChromaDex Corporation (CDXC) Fireside Chat
During this fireside chat Ben Shamsian, Vice President, Lytham Partners and Sean McGowan, Roth Capital Partners, chat with Rob Fried, Chief Executive Officer of ChromaDex Corporation. ChromaDex (NASDAQ:CDXC) is the global authority on nicotinamide adenine dinucleotide...
Jewett-Cameron (JCTC) Company Webcast
Jewett-Cameron's (Nasdaq: JCTC) business includes the manufacturing and distribution of patented and patent-pending specialty metal and sustainable bag products, and the wholesale distribution of wood products. This Company Webcast was recorded during the Lytham...
ChromaDex to Participate in a Fireside Chat at the Lytham Partners Fall 2024 Investor Conference
LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) with a focus on healthy-aging research, today announced that Rob Fried, CEO of ChromaDex and Founder of Tru Niagen, will participate in a fireside chat...
ChromaDex Appoints Ozan Pamir as Chief Financial Officer
LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging, announces the appointment of Ozan Pamir as Chief Financial Officer. Mr. Pamir will oversee all ChromaDex corporate...
ChromaDex Announces Expansion of Pharmaceutical-Grade Niagen® IV and Injection Offerings to Additional Leading Wellness Clinics
U.S. FDA-registered 503B outsourcing facility, Wells Pharma of Houston, will compound and distribute Niagen (nicotinamide riboside chloride) IV and injections to 14 new clinics LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine...
ChromaDex Celebrates 25 Years of Innovation and Pioneering NAD+ Research for Healthy Aging Solutions
Commemorating a quarter of a century with an exclusive 25% off lifelong subscription on Tru Niagen® LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging, proudly...
Transforming the Built Environment with Circular Design Technology
Design is the Key to More Sustainable ProductionARCO, Italy, Aug. 26, 2024 -- Aquafil SpA (ECNLF:OTCQX - ECNL:IM), based in Arco (TN) Italy and a pioneer of the circular economy, today released its second in a series of monographs that illustrate how we can design...
ChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow Series On Thursday, August 29, 2024
LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging, announced today that they will be participating in Renmark Financial Communications Inc.'s live Virtual Non-Deal...